Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Halbach

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
Quantitative Proteomics Analysis of Leukemia CellsSebastian Halbach, Jörn Dengjel, Tilman Brummer
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 29, 2015
Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell linesLucas Willmann, Manuel Schlimpert, Sebastian Halbach, et al.
Oncogene|January 13, 2018
BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell linesRicarda Herr, Sebastian Halbach, Miriam Heizmann, et al.
Cell Communication and Signaling : CCS|June 14, 2023
Analysis of RAS and drug induced homo- and heterodimerization of RAF and KSR1 proteins in living cells using split Nanoluc luciferaseLino Rohrer, Corinna Spohr, Carina Beha, et al.
Cell Communication and Signaling : CCS|February 26, 2016
Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cellsSebastian Halbach, Zehan Hu, Christine Gretzmeier, et al.
Cell Communication and Signaling : CCS|April 24, 2013
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cellsSebastian Halbach, Kristoffer Tg Rigbolt, Franziska U Wöhrle, et al.
Chemmedchem|December 9, 2015
Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) InterfaceDavid Bier, Maria Bartel, Katharina Sies, et al.
Leukemia|December 14, 2021
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivoCorinna Spohr, Teresa Poggio, Geoffroy Andrieux, et al.
Scientific Reports|August 22, 2015
Exometabolom analysis of breast cancer cell lines: Metabolic signatureLucas Willmann, Thalia Erbes, Sebastian Halbach, et al.
The EMBO Journal|April 19, 2012
Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signallingMichael Röring, Ricarda Herr, Gina J Fiala, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
Quantitative Proteomics Analysis of Leukemia CellsSebastian Halbach, Jörn Dengjel, Tilman Brummer
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 29, 2015
Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell linesLucas Willmann, Manuel Schlimpert, Sebastian Halbach, et al.
Oncogene|January 13, 2018
BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell linesRicarda Herr, Sebastian Halbach, Miriam Heizmann, et al.
Cell Communication and Signaling : CCS|June 14, 2023
Analysis of RAS and drug induced homo- and heterodimerization of RAF and KSR1 proteins in living cells using split Nanoluc luciferaseLino Rohrer, Corinna Spohr, Carina Beha, et al.
Cell Communication and Signaling : CCS|February 26, 2016
Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cellsSebastian Halbach, Zehan Hu, Christine Gretzmeier, et al.
Cell Communication and Signaling : CCS|April 24, 2013
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cellsSebastian Halbach, Kristoffer Tg Rigbolt, Franziska U Wöhrle, et al.
Chemmedchem|December 9, 2015
Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) InterfaceDavid Bier, Maria Bartel, Katharina Sies, et al.
Leukemia|December 14, 2021
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivoCorinna Spohr, Teresa Poggio, Geoffroy Andrieux, et al.
Scientific Reports|August 22, 2015
Exometabolom analysis of breast cancer cell lines: Metabolic signatureLucas Willmann, Thalia Erbes, Sebastian Halbach, et al.
The EMBO Journal|April 19, 2012
Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signallingMichael Röring, Ricarda Herr, Gina J Fiala, et al.
Pageof 3